Insider · CIK 0001500269

O'Leary Brendan

Reports to the SEC for 2 companies · NEEDHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001500269

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-06-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,666 sh	—	—	6,666
2015-06-02	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,666 sh	—	—	6,666
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	Director	CConversion	+375K sh	—	—	374,921
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	Director	CConversion	+180K sh	—	—	554,935
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	Director	CConversion	+181K sh	—	—	736,060
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	Director	CConversion	+192K sh	—	—	928,130
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	Director	CConversion	+252K sh	—	—	1,180,182
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	Director	CConversion	+124K sh	—	—	1,304,028
2014-10-27	TARAProtara Therapeutics, Inc.P Purchase	Director	PPurchase	+83.2K sh	$10.00	+$832K	1,387,198
2014-10-27	TARAProtara Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−5M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series A-1 Convertible Preferred StockC Conversion	Director	CConversion	−2.34M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion	Director	CConversion	−2.34M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion	Director	CConversion	−2.48M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series D Convertible Preferred StockC Conversion	Director	CConversion	−4M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Common Stock WarrantsD Disposition to Issuer	Director	DDisposition to Issuer	−1.97M sh	—	—	0
2013-09-11	Trius Therapeutics IncD Disposition to Issuer	Director	DDisposition to Issuer	−21.3K sh	—	—	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$9.50	−$114K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$5.24	−$62.9K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$8.45	−$101K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$5.73	−$86K	0
2013-05-21	Trius Therapeutics IncStock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2012-05-22	Trius Therapeutics IncStock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2012-03-26	Trius Therapeutics IncM Exercise/Conversion	Director	MExercise/Conversion	+9,302 sh	$1.29	+$12K	9,302
2012-03-26	Trius Therapeutics IncM Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$4.00	+$48K	21,302
2012-03-26	Trius Therapeutics IncStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,302 sh	—	—	0
2012-03-26	Trius Therapeutics IncStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	12,000
2011-06-02	Trius Therapeutics IncStock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2010-09-01	Trius Therapeutics IncStock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000

Recent filings

Accepted (ET)
Jun 144
PROTEON THERAPEUTICS INC0001171843-16-010646
SEC(opens sec.gov)
Jun 34
PROTEON THERAPEUTICS INC0001104659-15-043096
SEC(opens sec.gov)
Oct 294
PROTEON THERAPEUTICS INC0001012975-14-000687
SEC(opens sec.gov)
Sep 134
Trius Therapeutics Inc0001209191-13-044240
SEC(opens sec.gov)

Companies

Address

C/O PRISM VENTURE PARTNERS 117 KENDRICK STREET, STE. 200

NEEDHAM, MA, 02494